Complications relating to the heart and blood vessels in people with Cystic Fibrosis: A Review of the Literature
New drug for cystic fibrosis does not significantly interfere with another drug that prevents organ rejection
Emerging preclinical modulators developed for F508del-CFTR have the potential to be effective for ORKAMBI resistant processing mutants
Evidence of early increased sialylation of airway mucins and defective mucociliary clearance in CFTR-/- deficient piglets